[go: up one dir, main page]

ZA956986B - Methods of inhibiting viral replication. - Google Patents

Methods of inhibiting viral replication.

Info

Publication number
ZA956986B
ZA956986B ZA9506986A ZA956986A ZA956986B ZA 956986 B ZA956986 B ZA 956986B ZA 9506986 A ZA9506986 A ZA 9506986A ZA 956986 A ZA956986 A ZA 956986A ZA 956986 B ZA956986 B ZA 956986B
Authority
ZA
South Africa
Prior art keywords
viral replication
inhibiting viral
methods
image
hexamethyleneamino
Prior art date
Application number
ZA9506986A
Other languages
English (en)
Inventor
Andrew Lawrence Glasebrook
David Lynn Phillips
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA956986B publication Critical patent/ZA956986B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
ZA9506986A 1994-08-22 1995-08-21 Methods of inhibiting viral replication. ZA956986B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/294,171 US5494920A (en) 1994-08-22 1994-08-22 Methods of inhibiting viral replication

Publications (1)

Publication Number Publication Date
ZA956986B true ZA956986B (en) 1997-02-21

Family

ID=23132219

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9506986A ZA956986B (en) 1994-08-22 1995-08-21 Methods of inhibiting viral replication.

Country Status (15)

Country Link
US (1) US5494920A (fr)
EP (1) EP0771200B1 (fr)
JP (1) JPH10504572A (fr)
AT (1) ATE189601T1 (fr)
AU (1) AU3408795A (fr)
CA (1) CA2198122A1 (fr)
DE (1) DE69515038T2 (fr)
DK (1) DK0771200T3 (fr)
ES (1) ES2141957T3 (fr)
GR (1) GR3033269T3 (fr)
IL (1) IL115014A0 (fr)
MX (1) MX9701329A (fr)
PT (1) PT771200E (fr)
WO (1) WO1996005830A1 (fr)
ZA (1) ZA956986B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69636394T2 (de) 1995-12-13 2007-07-19 Merck & Co., Inc. Testverfahren für die sekretionsrezeptoren von wachstumshormonen
US6531314B1 (en) 1996-12-10 2003-03-11 Merck & Co., Inc. Growth hormone secretagogue receptor family
US6458811B1 (en) * 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
AU723797B2 (en) 1996-03-26 2000-09-07 Eli Lilly And Company Benzothiophenes, formulations containing same, and methods
WO2000066612A1 (fr) 1999-05-04 2000-11-09 Strakan Limited Glycosides d'androgenes et activite androgenique desdits glycosides
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
DE602005022924D1 (de) * 2004-12-08 2010-09-23 Cedars Sinai Medical Ct Los An Verfahren zur diagnose von morbus crohn
US20100021917A1 (en) * 2007-02-14 2010-01-28 Cedars-Sinai Medical Center Methods of using genes and genetic variants to predict or diagnose inflammatory bowel disease
WO2008106451A2 (fr) * 2007-02-26 2008-09-04 Cedars-Sinai Medical Center Procédés d'utilisation de polymorphismes nucléotidiques uniques dans le gène tl1a pour prédire ou diagnostiquer une affection intestinale inflammatoire
WO2010039931A2 (fr) * 2008-10-01 2010-04-08 Cedars-Sinai Medical Center Procédés d’utilisation de gènes de la voie il17rd et il23-il17 pour diagnostiquer la maladie de crohn
WO2008137762A2 (fr) * 2007-05-04 2008-11-13 Cedars-Sinai Medical Center Procédés de diagnostic et de traitement de la maladie de crohn
US20100015156A1 (en) * 2007-03-06 2010-01-21 Cedars-Sinai Medical Center Diagnosis of inflammatory bowel disease in children
US8486640B2 (en) 2007-03-21 2013-07-16 Cedars-Sinai Medical Center Ileal pouch-anal anastomosis (IPAA) factors in the treatment of inflammatory bowel disease
US20100184050A1 (en) * 2007-04-26 2010-07-22 Cedars-Sinai Medical Center Diagnosis and treatment of inflammatory bowel disease in the puerto rican population
US20100099640A1 (en) * 2007-05-04 2010-04-22 Joannes Geuns Tissue degeneration protection
US20110189685A1 (en) * 2008-10-22 2011-08-04 Cedars-Sinai Medical Center Methods of using jak3 genetic variants to diagnose and predict crohn's disease
WO2010062960A2 (fr) 2008-11-26 2010-06-03 Cedars-Sinai Medical Center Méthodes de détermination d'une réceptivité à une thérapie par anti-tnfα lors d’une maladie intestinale inflammatoire
WO2010075579A2 (fr) 2008-12-24 2010-07-01 Cedars-Sinai Medical Center Méthodes de prédiction de colite ulcéreuse réfractaire aux traitements (mr-uc) nécessitant une colectomie
WO2013190520A2 (fr) 2012-06-22 2013-12-27 The General Hospital Corporation Agents de libération de gh dans le traitement d'une sténose vasculaire et d'états associés
KR20210157418A (ko) 2013-03-27 2021-12-28 세다르스-신나이 메디칼 센터 Tl1a 기능 및 관련된 신호전달 경로의 저해에 의한 섬유증 및 염증의 완화 및 반전
EP4105236A1 (fr) 2013-07-19 2022-12-21 Cedars-Sinai Medical Center Anticorps contre tl1a (tnfsf15) pour le traitement des maladies inflammatoires de l'intestin
JP6649902B2 (ja) 2014-05-30 2020-02-19 ファイザー・インク 選択的アンドロゲン受容体モジュレーターとしてのカルボニトリル誘導体
CN109462996A (zh) 2016-03-17 2019-03-12 西达-赛奈医疗中心 通过rnaset2诊断炎性肠病的方法
WO2023275715A1 (fr) 2021-06-30 2023-01-05 Pfizer Inc. Métabolites de modulateurs sélectifs du récepteur des androgènes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体

Also Published As

Publication number Publication date
US5494920A (en) 1996-02-27
DE69515038D1 (de) 2000-03-16
MX9701329A (es) 1997-05-31
CA2198122A1 (fr) 1996-02-29
ATE189601T1 (de) 2000-02-15
EP0771200A4 (fr) 1997-09-10
IL115014A0 (en) 1995-12-08
PT771200E (pt) 2000-07-31
JPH10504572A (ja) 1998-05-06
AU3408795A (en) 1996-03-14
DK0771200T3 (da) 2000-05-15
ES2141957T3 (es) 2000-04-01
DE69515038T2 (de) 2000-06-29
WO1996005830A1 (fr) 1996-02-29
EP0771200A1 (fr) 1997-05-07
EP0771200B1 (fr) 2000-02-09
GR3033269T3 (en) 2000-09-29

Similar Documents

Publication Publication Date Title
ZA956986B (en) Methods of inhibiting viral replication.
MX9701360A (es) Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion.
MY132251A (en) Methods of inhibiting cell-cell adhesion
MX9701325A (es) Metodos para inhibir la mucositis ulcerativa.
AU7578794A (en) Methods for inhibiting endometriosis
DK0651999T3 (da) Fremgangsmåder til inhibering af livmoderfibrose
UA27910C2 (uk) Засіб для підвищення експресії тромбомодуліну та підвищення активації протеїну с
MY132085A (en) Methods for inhibiting bone prosthesis degeneration
MX9709466A (es) Medicamento para inhibir el melanoma.
MX9701333A (es) Metodos para inhibir el daño neuronal.
IL115016A0 (en) Methods for bone healing and fracture repair
MY113406A (en) Methods of inhibiting physiological conditions associated with an excess of bradykinin
MY113757A (en) Methods of inhibiting endometrial cancer
IL115018A0 (en) Methods of inhibiting primary endometrial hyperplasia
MX9709536A (es) Metodo para reducir el factor de transcripcion bef-1.
MX9709651A (es) Metodos para modulacion del factor de transcripcion nf-kb.
IL115023A0 (en) Methods of reducing scarring in wound healing
MX9705697A (es) Metodos para reducir los niveles de calcio del suero.
MX9806036A (es) Compuestos para inhibir tumores en el colon.